Pharming Group N.V.
PHARM.AS · AMS
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €53,037 | €61,741 | €207,342 | €191,725 |
| Short-Term Investments | €109,030 | €151,683 | €0 | €0 |
| Receivables | €48,452 | €42,615 | €19,578 | €15,882 |
| Inventory | €53,814 | €56,760 | €42,326 | €27,282 |
| Other Curr. Assets | €4,693 | €13,752 | €2,501 | €2,619 |
| Total Curr. Assets | €269,025 | €316,342 | €277,500 | €249,185 |
| Property Plant & Equip (Net) | €23,307 | €33,466 | €39,145 | €33,131 |
| Goodwill | -€25 | €0 | €0 | -€87 |
| Intangibles | €58,946 | €71,267 | €75,121 | €83,834 |
| Long-Term Investments | €4,233 | €9,419 | €9,731 | €9,949 |
| Tax Assets | €30,544 | €29,761 | €22,973 | €21,194 |
| Other NC Assets | €850 | €2,599 | €1,327 | -€303 |
| Total NC Assets | €117,854 | €146,512 | €148,297 | €147,717 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €386,880 | €462,854 | €425,797 | €396,902 |
| Liabilities | – | – | – | – |
| Payables | €9,757 | €14,504 | €6,075 | €5,137 |
| Short-Term Debt | €6,942 | €5,440 | €5,233 | €2,421 |
| Tax Payable | €3,284 | €6,234 | €2,099 | €1,505 |
| Deferred Revenue | €0 | €0 | -€56 | -€44 |
| Other Curr. Liab. | €53,819 | €51,790 | €42,345 | €32,029 |
| Total Curr. Liab. | €73,802 | €77,968 | €59,698 | €46,721 |
| LT Debt | €101,474 | €166,105 | €152,761 | €140,588 |
| Deferred Rev, NC | €0 | €0 | €0 | €0 |
| Deferred Tax Liab, NC | €0 | €0 | €0 | €0 |
| Other NC Liab. | €0 | €0 | €8,700 | €17,040 |
| Total NC Liab. | €101,474 | €166,105 | €161,461 | €157,465 |
| Other Liabilities | -€2,560 | €0 | €0 | €0 |
| Cap. Leases | €28,877 | €33,123 | €33,308 | €20,875 |
| Total Liabilities | €172,716 | €244,073 | €221,159 | €204,186 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €0 | €0 |
| Common Stock | €7,769 | €6,947 | €7,509 | €7,275 |
| Retained Earnings | -€265,358 | -€265,262 | -€256,431 | -€269,447 |
| AOCI | -€202 | -€1,862 | -€8,737 | €2,170 |
| Other Equity | €471,752 | €478,959 | €462,297 | €462,683 |
| Total Equity | €214,163 | €218,781 | €204,638 | €192,716 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €386,880 | €462,854 | €425,797 | €396,902 |
| Net Debt | €55,379 | €109,804 | -€49,348 | -€48,716 |